SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Dow Inc., et al. – ‘10-Q’ for 9/30/19 – ‘R12’

On:  Friday, 10/25/19, at 8:02am ET   ·   For:  9/30/19   ·   Accession #:  1751788-19-31   ·   File #s:  1-03433, 1-38646

Previous ‘10-Q’:  ‘10-Q’ on 7/25/19 for 6/30/19   ·   Next:  ‘10-Q’ on 5/1/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 4/26/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/25/19  Dow Inc.                          10-Q        9/30/19  122:20M
          Dow Chemical Co/DE

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.80M 
 2: EX-23       Ankura Consulting Group, LLC's Consent              HTML     40K 
 3: EX-31.1     Certification Pursuant to Section 302 of the        HTML     41K 
                Sarbanes-Oxley Act of 2002                                       
 4: EX-31.2     Certification Pursuant to Section 302 of the        HTML     41K 
                Sarbanes-Oxley Act of 2002                                       
 5: EX-32.1     Certification Pursuant to Section 906 of the        HTML     36K 
                Sarbanes-Oxley Act of 2002                                       
 6: EX-32.2     Certification Pursuant to Section 906 of the        HTML     36K 
                Sarbanes-Oxley Act of 2002                                       
105: R1          Cover Page                                          HTML     95K  
67: R2          Dow Consolidated Statements of Income Statement     HTML    136K 
24: R3          Dow Consolidated Statements of Comprehensive        HTML     68K 
                Income Statement                                                 
87: R4          Dow Consolidated Balance Sheets Statement           HTML    188K 
103: R5          Dow Consolidated Balance Sheets Parentheticals      HTML     63K  
65: R6          Dow Consolidated Statements of Cash Flows           HTML    176K 
                Statement                                                        
22: R7          Dow Consolidated Statements of Equity Statement     HTML    111K 
90: R8          Consolidated Statements of Income                   HTML    110K 
101: R9          Consolidated Statements of Comprehensive Income     HTML     72K  
38: R10         Consolidated Balance Sheets                         HTML    205K 
50: R11         Consolidated Balance Sheets (Parentheticals)        HTML     67K 
119: R12         TDCC Consolidated Statements of Cash Flows          HTML    194K  
                Statement                                                        
77: R13         Consolidated Statements of Equity                   HTML    104K 
37: R14         Consolidated Statements of Equity (Parenthetical)   HTML     38K 
49: R15         Consolidated Financial Statements                   HTML     54K 
118: R16         Recent Accounting Guidance                          HTML     42K  
76: R17         SEPARATION FROM DOWDUPONT Separation from           HTML    116K 
                DowDuPont (Notes)                                                
36: R18         Revenue (Notes)                                     HTML    112K 
51: R19         Restructuring and Asset Related Charges - Net       HTML    164K 
99: R20         Supplementary Information                           HTML     43K 
86: R21         Earnings Per Share (Notes)                          HTML    102K 
13: R22         Inventories                                         HTML     47K 
54: R23         Nonconsolidated Affiliates                          HTML     48K 
98: R24         Goodwill and Other Intangible Assets                HTML    100K 
85: R25         Transfers of Financial Assets                       HTML     42K 
12: R26         Notes Payable, Long-Term Debt and Available Credit  HTML    133K 
                Facilities                                                       
53: R27         Commitments and Contingent Liabilities              HTML     86K 
100: R28         Leases (Notes)                                      HTML    116K  
84: R29         Stockholders' Equity Stockholders' Equity (Notes)   HTML    169K 
78: R30         NONCONTROLLING INTERESTS Noncontrolling Interests   HTML     66K 
121: R31         Pension Plans and Other Postretirement Benefits     HTML     87K  
47: R32         Stock-Based Compensation                            HTML     44K 
34: R33         Financial Instruments                               HTML    280K 
79: R34         Fair Value Measurements                             HTML    108K 
122: R35         Variable Interest Entities                          HTML     67K  
48: R36         Relatd Party Transactions (Notes)                   HTML     57K 
35: R37         Segments and Geographic Regions (Notes)             HTML    232K 
80: R38         Consolidated Financial Statements Summary of        HTML     50K 
                Significant Accounting Policies (Policies)                       
120: R39         SEPARATION FROM DOWDUPONT Separation from           HTML    106K  
                DowDuPont (Tables)                                               
88: R40         Revenue (Tables)                                    HTML    106K 
104: R41         Restructuring and Asset Related Charges - Net       HTML     38K  
                (Tables)                                                         
64: R42         Earnings Per Share (Tables)                         HTML    102K 
21: R43         Inventories (Tables)                                HTML     49K 
89: R44         Nonconsolidated Affiliates (Tables)                 HTML     42K 
106: R45         Goodwill and Other Intangible Assets (Tables)       HTML    102K  
66: R46         Transfers of Financial Assets (Tables)              HTML     41K 
23: R47         Notes Payable, Long-Term Debt and Available Credit  HTML    132K 
                Facilities (Tables)                                              
91: R48         Commitments and Contingent Liabilities (Tables)     HTML     45K 
102: R49         Leases (Tables)                                     HTML    136K  
112: R50         Stockholders' Equity Stockholders' Equity (Tables)  HTML    169K  
71: R51         NONCONTROLLING INTERESTS Noncontrolling Interests   HTML     64K 
                (Tables)                                                         
33: R52         Pension Plans and Other Postretirement Benefits     HTML     84K 
                (Tables)                                                         
46: R53         Financial Instruments (Tables)                      HTML    262K 
111: R54         Fair Value Measurements (Tables)                    HTML     99K  
70: R55         Variable Interest Entities (Tables)                 HTML     69K 
32: R56         Related Party Transactions (Tables)                 HTML     50K 
45: R57         Segments and Geographic Regions (Tables)            HTML    232K 
113: R58         CONSOLIDATED FINANCIAL STATEMENTS Changes to        HTML     47K  
                Statement of Equity (Details)                                    
69: R59         RECENT ACCOUNTING GUIDANCE Recent Accounting        HTML     39K 
                Guidance (Details)                                               
19: R60         SEPARATION FROM DOWDUPONT Separation from           HTML     52K 
                DowDuPont (Details)                                              
60: R61         SEPARATION FROM DOWDUPONT Receipt of ECP (Details)  HTML     99K 
109: R62         SEPARATION FROM DOWDUPONT Discontinued Operations   HTML     84K  
                - Income Statement (Details)                                     
94: R63         SEPARATION FROM DOWDUPONT Discontinued Operations   HTML    108K 
                - Balance Sheet (Details)                                        
18: R64         SEPARATION FROM DOWDUPONT Separation, Distribution  HTML     58K 
                and Tax Agreements (Details)                                     
59: R65         Revenue (Details)                                   HTML     96K 
108: R66         Restructuring and Asset Related Charges - Net       HTML     39K  
                Restructuring and Asset Related Charges - Net                    
                (Other) (Details)                                                
93: R67         Restructuring and Asset Related Charges - Net       HTML    111K 
                (DowDuPont Cost Synergy Program) (Details)                       
15: R68         Restructuring and Asset Related Charges - Net       HTML     47K 
                Restructuring and Asset Related Charges - Net                    
                (Asset Related Charges) (Details)                                
62: R69         Summary of Sundry Income (Expense) - Net (Details)  HTML     86K 
42: R70         Earnings Per Share (Details)                        HTML    113K 
26: R71         Inventories (Schedule of Inventories) (Details)     HTML     50K 
73: R72         Nonconsolidated Affiliates (Details)                HTML     52K 
115: R73         GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of   HTML     53K  
                Goodwill (Details)                                               
43: R74         GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of   HTML     62K 
                Other Intangible Assets (Details)                                
27: R75         GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of   HTML     42K 
                Amortization Expense (Details)                                   
74: R76         GOODWILL AND OTHER INTANGIBLE ASSETS - Summary of   HTML     48K 
                Future Amortization Expense (Details)                            
116: R77         TRANSFERS OF FINANCIAL ASSETS - Cash Proceeds       HTML     35K  
                (Details)                                                        
40: R78         NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT  HTML     48K 
                FACILITIES Notes Payable (Details)                               
31: R79         NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT  HTML    187K 
                FACILITIES Long-Term Debt (Details)                              
41: R80         NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT  HTML     75K 
                FACILITIES Committed and Available Credit                        
                Facilities (Details)                                             
25: R81         NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT  HTML     37K 
                FACILITIES Debt Covenant and Default Provisions                  
                (Details)                                                        
72: R82         Commitments and Contingent Liabilities              HTML     57K 
                (Environmental Matters) (Narrative) (Details)                    
114: R83         Commitments and Contingent Liabilities              HTML     42K  
                (Asbestos-Related Matters of Union Carbide                       
                Corporation) (Table and Narrative) (Details)                     
44: R84         Commitments and Contingent Liabilites (Dow          HTML     73K 
                Silicones Chapter 11 Related Matters) (Details)                  
                (Details)                                                        
28: R85         COMMITMENTS AND CONTINGENT LIABILITIES              HTML     49K 
                Indemnifications with Corning (Details)                          
75: R86         Commitments and Contingent Liabilities (Nova        HTML     53K 
                Patent Infringement Matter) (Details)                            
117: R87         Commitments and Contingent Liabilities Nova         HTML     56K  
                Ethylene Asset Matter (Details)                                  
39: R88         Commitments and Contingent Liabilities              HTML     57K 
                (Guarantees) (Table and Narrative) (Details)                     
29: R89         Leases (Details)                                    HTML    161K 
20: R90         STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY - Common  HTML     60K 
                Stock (Details)                                                  
61: R91         STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY -         HTML     39K 
                Retained Earnings (Details)                                      
110: R92         STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY -         HTML     40K  
                Treasury Stock (Details)                                         
95: R93         STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY -         HTML    107K 
                Accumulated Other Comprehensive Loss (Details)                   
17: R94         NONCONTROLLING INTERESTS Noncontrolling Interests   HTML     78K 
                (Details)                                                        
58: R95         Pension Plans and Other Postretirement Benefits     HTML     84K 
                (Details)                                                        
107: R96         Stock-Based Compensation (Stock Incentive Plan)     HTML     62K  
                (Details)                                                        
92: R97         FINANCIAL INSTRUMENTS Fair Value of Financial       HTML    142K 
                Instruments (Details)                                            
16: R98         FINANCIAL INSTRUMENTS Derivatives (Details)         HTML    209K 
63: R99         Fair Value Measurements (Summary of Recurring       HTML    108K 
                Measured Fair Values) (Details)                                  
82: R100        Fair Value Measurements Fair Value Measurements     HTML     99K 
                (Summary of Nonrecurring Measured Fair Values)                   
                (Details)                                                        
96: R101        Variable Interest Entities (Schedule of             HTML     74K 
                Consolidated Variable Interest Entities, Carrying                
                Amounts of Assets and Liabilities) (Details)                     
55: R102        Variable Interest Entities (Nonconsolidated         HTML     45K 
                Variable Interest Entity) (Details)                              
14: R103        Relatd Party Transactions (Details)                 HTML     64K 
83: R104        SEGMENTS AND GEOGRAPHIC REGIONS Segment             HTML     64K 
                Information (Details)                                            
97: R105        SEGMENTS AND GEOGRAPHIC REGIONS EBIT                HTML     57K 
                Reconciliation (Details)                                         
57: R106        SEGMENTS AND GEOGRAPHIC REGIONS Significant Items   HTML     89K 
                (Details)                                                        
30: XML         IDEA XML File -- Filing Summary                      XML    231K 
56: XML         XBRL Instance -- dowinc-q3x9302019_htm               XML   6.27M 
68: EXCEL       IDEA Workbook of Financial Reports                  XLSX    165K 
 8: EX-101.CAL  XBRL Calculations -- dow-20190930_cal                XML    195K 
 9: EX-101.DEF  XBRL Definitions -- dow-20190930_def                 XML   1.84M 
10: EX-101.LAB  XBRL Labels -- dow-20190930_lab                      XML   2.73M 
11: EX-101.PRE  XBRL Presentations -- dow-20190930_pre               XML   2.17M 
 7: EX-101.SCH  XBRL Schema -- dow-20190930                          XSD    286K 
81: JSON        XBRL Instance as JSON Data -- MetaLinks              558±   862K 
52: ZIP         XBRL Zipped Folder -- 0001751788-19-000031-xbrl      Zip    554K 


‘R12’   —   TDCC Consolidated Statements of Cash Flows Statement


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.19.3
TDCC Consolidated Statements of Cash Flows Statement - USD ($)
$ in Millions
9 Months Ended
Net income $ 1,038 $ 3,852
Income from discontinued operations, net of tax 445 1,403
Income from continuing operations, net of tax 593 2,449
Depreciation and amortization 2,225 2,183
Provision (credit) for deferred income tax (146) 5
Earnings of nonconsolidated affiliates less than dividends received (927) (81)
Net periodic pension benefit cost 101 252
Pension contributions (206) (1,533)
Net gain on sales of assets, businesses and investments 48 24
Adjustment to gain on step acquisition of nonconsolidated affiliate 0 (20)
Restructuring and asset related charges - net 368 175
Other net loss (143) (327)
Accounts and notes receivable (994) 1,422
Inventories (483) 1,120
Accounts payable (926) 1,453
Other assets and liabilities, net 715 1,139
Cash provided by operating activities - continuing operations 3,793 1,707
Cash provided by operating activities - discontinued operations 187 817
Cash provided by operating activities 3,980 2,524
Capital expenditures (1,384) (1,445)
Investment in gas field developments (71) (82)
Purchases of previously leased assets (9) 0
Proceeds from sales of property and businesses, net of cash divested 47 15
Acquisitions of property and businesses, net of cash acquired 0 20
Investments in and loans to nonconsolidated affiliates (333) (11)
Distributions and loan repayments from nonconsolidated affiliates 0 55
Purchases of investments (784) (1,301)
Proceeds from sales and maturities of investments 973 1,025
Proceeds from interests in trade accounts receivable conduits 0 657
Cash used for investing activities - continuing operations (1,561) (1,107)
Cash used for investing activities - discontinued operations (34) (203)
Cash used for investing activities (1,595) (1,310)
Changes in short-term notes payable 149 425
Proceeds from issuance of long-term debt 2,146 0
Payments on long-term debt (4,271) (859)
Proceeds from issuance of parent company stock 39 106
Transaction financing, debt issuance and other costs (61) 0
Employee taxes paid for share-based payment arrangements (54) (76)
Distributions to noncontrolling interests (16) (41)
Purchases of noncontrolling interests (131) 0
Dividends paid to DowDuPont Inc. (535) (3,158)
Settlements and transfers related to separation from DowDuPont Inc. (1,935) 276
Other financing activities, net 0 2
Cash used for financing activities - continuing operations (2,238) (3,877)
Cash used for financing activities - discontinued operations (18) (44)
Cash used for financing activities (2,256) (3,921)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (54) (59)
Decrease in cash, cash equivalents and restricted cash 75 (2,766)
Cash, cash equivalents and restricted cash at beginning of period 2,764 6,208
Cash, cash equivalents and restricted cash at end of period 2,839 3,442
Less: Restricted cash and cash equivalents, included in Other current assets 16 31
Cash and cash equivalents at end of period 2,823 3,411
The Dow Chemical Company [Domain]    
Net income 1,142 3,852
Income from discontinued operations, net of tax 445 1,403
Income from continuing operations, net of tax 697 2,449
Depreciation and amortization 2,225 2,183
Provision (credit) for deferred income tax (146) 5
Earnings of nonconsolidated affiliates less than dividends received 927 81
Net periodic pension benefit cost 101 252
Pension contributions (206) (1,533)
Net gain on sales of assets, businesses and investments (48) (24)
Adjustment to gain on step acquisition of nonconsolidated affiliate 0 20
Restructuring and asset related charges - net 368 175
Other net loss 157 327
Accounts and notes receivable 994 (1,422)
Inventories 483 (1,120)
Accounts payable (926) 1,453
Other assets and liabilities, net (860) (1,139)
Cash provided by operating activities - continuing operations 3,766 1,707
Cash provided by operating activities - discontinued operations 371 817
Cash provided by operating activities 4,137 2,524
Capital expenditures (1,384) (1,445)
Investment in gas field developments (71) (82)
Purchases of previously leased assets (9) 0
Proceeds from sales of property and businesses, net of cash divested 47 15
Acquisitions of property and businesses, net of cash acquired 0 20
Investments in and loans to nonconsolidated affiliates (333) (11)
Distributions and loan repayments from nonconsolidated affiliates 0 55
Purchases of investments (784) (1,301)
Proceeds from sales and maturities of investments 973 1,025
Proceeds from interests in trade accounts receivable conduits 0 657
Cash used for investing activities - continuing operations (1,561) (1,107)
Cash used for investing activities - discontinued operations (34) (203)
Cash used for investing activities (1,595) (1,310)
Changes in short-term notes payable 149 425
Changes in notes payable with Dow Inc. 400 0
Proceeds from issuance of long-term debt 2,146 0
Payments on long-term debt (4,271) (859)
Proceeds from issuance of parent company stock 39 106
Transaction financing, debt issuance and other costs (61) 0
Employee taxes paid for share-based payment arrangements (54) (76)
Distributions to noncontrolling interests (16) (41)
Purchases of noncontrolling interests (131) 0
Dividends paid to DowDuPont Inc. (535) (3,158)
Settlements and transfers related to separation from DowDuPont Inc. (61) (276)
Other financing activities, net 0 2
Cash used for financing activities - continuing operations (2,395) (3,877)
Cash used for financing activities - discontinued operations (18) (44)
Cash used for financing activities (2,413) (3,921)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (54) (59)
Decrease in cash, cash equivalents and restricted cash 75 (2,766)
Cash, cash equivalents and restricted cash at beginning of period 2,764 6,208
Cash, cash equivalents and restricted cash at end of period 2,839 3,442
Less: Restricted cash and cash equivalents, included in Other current assets 16 31
Cash and cash equivalents at end of period $ 2,823 $ 3,411

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/25/19
For Period end:9/30/1913F-HR
9/30/1810-Q,  13F-HR
 List all Filings 
Top
Filing Submission 0001751788-19-000031   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 3:44:35.1pm ET